President Donald Trump’s $3 billion funding freeze on Harvard University is starting to have an impact on the local real ...

A revolutionary immunotherapy has stunned doctors by making an aggressive, previously incurable blood cancer vanish in some ...

The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Prospective parents using in vitro fertilization (IVF) will soon be able to select embryos based on their potential risk for ...

Ann Arbor-based biotech company Akadeum Life Sciences Inc. raised more than $20 million in a recent financing round, the ...

NIH funding cuts will negatively affect Utah research facilities, weakening Utah’s competitive edge in science and technology ...

On May 22, 2025, the U.S. House of Representatives passed a reconciliation bill (commonly referred to as the “One Big Beautiful Bill”), which ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National ...

Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

TegMine has identified Taiwan’s OBI as a company that can help advance its ambitions. The new deal secures TegMine the right ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.